Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1Classical hematology 1

Conditions

Ulcer 1Stomatitis 1Stomach Neoplasms 1Speech 1Radiation Injuries 1Pain 1Neuroendocrine Tumors 1Mucositis 1Head and Neck Neoplasms 1Anemia, Iron-Deficiency 1

Interventions

Oxaliplatin 42Fluorouracil 27Capecitabine 24pembrolizumab 21S 1 (combination) 19Paclitaxel 19Leucovorin 16Nivolumab 13Docetaxel 13sintilimab 12Drug Therapy 12tislelizumab 10Trastuzumab 10Cisplatin 10Irinotecan 9Bevacizumab 8trastuzumab deruxtecan 7spartalizumab 7XELOX 7Surgical Procedures, Operative 7Radiotherapy 7Hyperthermic Intraperitoneal Chemotherapy 7Biopsy 7fludarabine 6disitamab vedotin 6Cyclophosphamide 6lenvatinib 5apatinib 5Specimen Handling 5Ramucirumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Stomach Neoplasms × Betaine × Clear all
NCT06881511 2025-03-30

Exploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Recruiting
100 enrolled
Classical hematologyEndocrineGastrointestinalNET

Stomach Neoplasms, Neuroendocrine Tumors, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡